Australia markets open in 2 hours 37 minutes

Cencora, Inc. (COR)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
234.70+2.17 (+0.93%)
At close: 04:00PM EDT
234.70 0.00 (0.00%)
After hours: 04:58PM EDT

Cencora, Inc.

1 West First Avenue
Conshohocken, PA 19428-1800
United States
610 727 7000
https://www.cencora.com

Sector(s)Healthcare
IndustryMedical Distribution
Full-time employees46,000

Key executives

NameTitlePayExercisedYear born
Mr. Steven H. CollisChairman, President & CEO5.01M13.79M1961
Mr. James F. Cleary Jr.Executive VP & CFO1.95M3.8M1963
Dr. Robert P. Mauch Ph.D., PharmDExecutive VP & COO2.7MN/A1967
Ms. Gina K. ClarkExecutive VP and Chief Communications & Administration Officer1.57M5.01M1957
Ms. Elizabeth S. CampbellExecutive VP & Chief Legal Officer1.63M318.67k1975
Mr. Lazarus KrikorianSenior VP, Chief Accounting Officer & Corporate ControllerN/AN/A1965
Bennett S. MurphySenior Vice President of Investor RelationsN/AN/AN/A
Ms. Jennifer E. DubasSenior VP & Chief Compliance OfficerN/AN/AN/A
Ms. Silvana BattagliaExecutive VP & Chief Human Resources Officer1.58MN/A1968
Ms. Leslie E. DonatoExecutive VP & Chief Strategy OfficerN/AN/A1970
Amounts are as of 31 December 2023, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Cencora, Inc. sources and distributes pharmaceutical products. The company's U.S. Healthcare Solutions segment distributes pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical clinics, long-term care and alternate site pharmacies, and other customers; provides pharmacy management, staffing, and other consulting services; supply management software to retail and institutional healthcare providers; packaging solutions to various institutional and retail healthcare providers; clinical trial support, product post-approval, and commercialization support services; data analytics, outcomes research, and additional services for biotechnology and pharmaceutical manufacturers; pharmaceuticals, vaccines, parasiticides, diagnostics, micro feed ingredients, and other products to the companion animal and production animal markets; and sales force services to manufacturers. This segment also distributes plasma and other blood products, injectable pharmaceuticals, vaccines, and other specialty products; and provides other services to physicians who specialize in various disease states, such as oncology, as well as to other healthcare providers, including hospitals and dialysis clinics. Its International Healthcare Solutions segment offers international pharmaceutical wholesale and related service, and global commercialization services; distributes pharmaceuticals, other healthcare products, and related services to pharmacies, doctors, health centers, and hospitals primarily in Europe; and provides specialty transportation and logistics services for the biopharmaceutical industry. The company was formerly known as AmerisourceBergen Corporation and changed its name to Cencora, Inc. in August 2023. Cencora, Inc. was incorporated in 2001 and is headquartered in Conshohocken, Pennsylvania.

Corporate governance

Cencora, Inc.’s ISS governance QualityScore as of 1 June 2024 is 3. The pillar scores are Audit: 2; Board: 5; Shareholder rights: 7; Compensation: 2.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.